Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

New compounds show promise as nonsteroidal treatments for hair loss.

The document concludes that a compound with potential for treating prostate cancer and hair loss was successfully made and its detailed structure was confirmed.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

2,5-DBH shows promise for improving drugs in cancer, brain disorders, and infections.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

PXX is an effective and affordable photocatalyst for creating new chemical bonds in organic synthesis.

A new method using solid-state circular dichroism anisotropy can distinguish similar chiral compounds better than traditional techniques.

Compound 15a was effective in inhibiting 5α-reductase.

Analog 23 is a promising compound for prostate cancer treatment.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Researchers made new compounds that could potentially be developed into anticancer drugs.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Finasteride complexes with HPβCD and polymers improve solubility, potentially enhancing hair loss treatment.

A new compound that could treat various androgen-related conditions was created and analyzed.

A new compound was made to detect copper ions effectively.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Scientists made two new chemicals that might help treat diseases caused by male hormones.